Are T cell ‘engagers’ the next big thing in autoimmune disease treatment?
Source Science 科学52m ago
Summary
Engineered antibodies may produce remissions and offer safety benefits over cell therapies that have killed patients
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Science
- Region
- Americas
- Language
- English
- Item ID
- science-da991458
Comments 0 comments
No comments yet. Be the first.